Switch theme
Sign up to access all valuation multiples
Shanghai Chicmax Cosmetic Co Ltd is a China-based multi-brand cosmetics company mainly engaged in the research, development, production, and sales of skincare, maternity, and childcare products. It offers a wide range of cosmetics products under various brands, including KANS, One Leaf, and Baby Elephant. The company's products include skin care products, maternal and childcare products, toiletries, and others. The company also operates brands such as BIO-G, KYOCA, ARMIYO, TAZU, and others.
2004
2.1K+
LTM Revenue $1.1B
LTM EBITDA $163M
$3.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Chicmax Cosmetic has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of $163M.
In the most recent fiscal year, Chicmax Cosmetic achieved revenue of $867M and an EBITDA of $133M.
Chicmax Cosmetic expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chicmax Cosmetic valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $867M | XXX | XXX | XXX |
| Gross Profit | $850M | XXX | $652M | XXX | XXX | XXX |
| Gross Margin | 76% | XXX | 75% | XXX | XXX | XXX |
| EBITDA | $163M | XXX | $133M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBIT | $141M | XXX | $118M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $132M | XXX | $99.7M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Chicmax Cosmetic's stock price is HKD 66 (or $8).
Chicmax Cosmetic has current market cap of HKD 26.1B (or $3.3B), and EV of HKD 25.4B (or $3.2B).
See Chicmax Cosmetic trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.2B | $3.3B | XXX | XXX | XXX | XXX | $0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Chicmax Cosmetic has market cap of $3.3B and EV of $3.2B.
Chicmax Cosmetic's trades at 3.7x EV/Revenue multiple, and 24.5x EV/EBITDA.
Equity research analysts estimate Chicmax Cosmetic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chicmax Cosmetic has a P/E ratio of 27.5x.
See valuation multiples for Chicmax Cosmetic and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| EV (current) | $3.2B | XXX | $3.2B | XXX | XXX | XXX |
| EV/Revenue | 3.1x | XXX | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | 21.6x | XXX | 24.5x | XXX | XXX | XXX |
| EV/EBIT | 25.0x | XXX | 27.6x | XXX | XXX | XXX |
| EV/Gross Profit | 4.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.5x | XXX | 33.4x | XXX | XXX | XXX |
| EV/FCF | 107.9x | XXX | 83.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChicmax Cosmetic's last 12 month revenue growth is 24%
Chicmax Cosmetic's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Chicmax Cosmetic's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chicmax Cosmetic's rule of X is 75% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Chicmax Cosmetic and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | 40% | XXX | 39% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 75% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 58% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 62% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chicmax Cosmetic acquired XXX companies to date.
Last acquisition by Chicmax Cosmetic was XXXXXXXX, XXXXX XXXXX XXXXXX . Chicmax Cosmetic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Chicmax Cosmetic founded? | Chicmax Cosmetic was founded in 2004. |
| Where is Chicmax Cosmetic headquartered? | Chicmax Cosmetic is headquartered in Hong Kong. |
| How many employees does Chicmax Cosmetic have? | As of today, Chicmax Cosmetic has 2.1K+ employees. |
| Who is the CEO of Chicmax Cosmetic? | Chicmax Cosmetic's CEO is Mr. Yixiong Lyu. |
| Is Chicmax Cosmetic publicy listed? | Yes, Chicmax Cosmetic is a public company listed on HKG. |
| What is the stock symbol of Chicmax Cosmetic? | Chicmax Cosmetic trades under 02145 ticker. |
| When did Chicmax Cosmetic go public? | Chicmax Cosmetic went public in 2022. |
| Who are competitors of Chicmax Cosmetic? | Similar companies to Chicmax Cosmetic include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Chicmax Cosmetic? | Chicmax Cosmetic's current market cap is $3.3B |
| What is the current revenue of Chicmax Cosmetic? | Chicmax Cosmetic's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Chicmax Cosmetic? | Chicmax Cosmetic revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Chicmax Cosmetic? | Current revenue multiple of Chicmax Cosmetic is 3.1x. |
| Is Chicmax Cosmetic profitable? | Yes, Chicmax Cosmetic is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Chicmax Cosmetic? | Chicmax Cosmetic's last 12 months EBITDA is $163M. |
| What is Chicmax Cosmetic's EBITDA margin? | Chicmax Cosmetic's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Chicmax Cosmetic? | Current EBITDA multiple of Chicmax Cosmetic is 21.6x. |
| What is the current FCF of Chicmax Cosmetic? | Chicmax Cosmetic's last 12 months FCF is $32.7M. |
| What is Chicmax Cosmetic's FCF margin? | Chicmax Cosmetic's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Chicmax Cosmetic? | Current FCF multiple of Chicmax Cosmetic is 107.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
